Rotterdam, Netherlands

Michiel De Maat


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michiel De Maat: Innovator in Gastric Cancer Research

Introduction

Michiel De Maat is a prominent inventor based in Rotterdam, Netherlands. He has made significant contributions to the field of cancer research, particularly in understanding gastric cancer. With two patents to his name, his work focuses on innovative methods that can improve patient outcomes.

Latest Patents

One of Michiel De Maat's latest patents is titled "Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer." This invention discloses methods of using the methylation status of the COX-2 gene promoter region as a biomarker for gastric cancer patients. It aims to determine prognosis and treatment regimens while also monitoring the progress of these treatments. This innovative approach has the potential to significantly impact clinical practices in oncology.

Career Highlights

Michiel De Maat is associated with the John Wayne Cancer Institute, where he continues to advance research in cancer treatment. His work is characterized by a commitment to improving the understanding of cancer biology and developing new therapeutic strategies.

Collaborations

He collaborates with notable professionals in the field, including his coworker Dave S B Hoon. Their combined expertise contributes to the ongoing research efforts at the institute.

Conclusion

In summary, Michiel De Maat is an influential inventor whose work in gastric cancer research is paving the way for innovative treatment approaches. His patents reflect a dedication to enhancing patient care and outcomes in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…